By Taylor Mixides (Drug Target Review)2023-08-21T12:52:52
Human papillomavirus (HPV)-associated head and neck cancers, specifically head and neck squamous cell carcinoma (HNSCC), are on the rise worldwide. Yet, the factors contributing to these tumours and their varying responses to treatment remain poorly understood.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-03-28T11:38:32
Sponsored by Bio-Techne
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2024-01-24T12:52:38
Sponsored by BellBrook Labs
Site powered by Webvision Cloud